Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 Å resolution

被引:135
作者
van Raaij, MJ
Chouin, E
van der Zandt, H
Bergelson, JM
Cusack, S
机构
[1] Inst Max Von Laue Paul Langevin, European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France
[2] European Mol Biol Lab, D-69117 Heidelberg, Germany
[3] Childrens Hosp Philadelphia, Div Infect Dis & Immunol, Philadelphia, PA 19104 USA
关键词
coxsackievirus and adenovirus receptor; IgV domain; homodimer; cell adhesion; analytical ultracentrifugation; receptor-ligand interaction;
D O I
10.1016/S0969-2126(00)00528-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The coxsackievirus and adenovirus receptor (CAR) comprises two extracellular immunoglobulin domains, a transmembrane helix and a C-terminal intracellular domain. The amino-terminal immunoglobulin domain (D1) of CAR is necessary and sufficient for adenovirus binding, whereas the site of coxackievirus attachment has not yet been localized. The normal cellular role of CAR is currently unknown, although CAR was recently proposed to function as a hemophilic cell adhesion molecule. Results: The human CAR D1 domain was bacterially expressed and crystallized. The structure was solved by molecular replacement using the structure of CAR D1 bound to the adenovirus type 12 fiber head and refined to 1.7 Angstrom resolution, including individual anisotropic temperature factors. The two CAR D1 structures are virtually identical, apart from the BC, C"D, and FG loops that are involved both in fiber head binding and homodimerization in the crystal. Analytical equilibrium ultracentrifugation shows that a dimer also exists in solution, with a dissociation constant of 16 muM. Conclusions: The CAR D1 domain forms homodimers in the crystal using the same GFCC'C" surface that interacts with the adenovirus fiber head. The homodimer is very similar to the CD2 D1-CD58 D1 heterodimer. CAR D1 also forms dimers in solution with a dissociation constant typical of other cell adhesion complexes. These results are consistent with reports that CAR may function physiologically as a homophilic cell adhesion molecule in the developing mouse brain. Adenovirus may thus have recruited an existing and conserved interaction surface of CAR to use for its own cell attachment.
引用
收藏
页码:1147 / 1155
页数:9
相关论文
共 48 条
[1]   Adenovirus type 37 uses sialic acid as a cellular receptor [J].
Arnberg, N ;
Edlund, K ;
Kidd, AH ;
Wadell, G .
JOURNAL OF VIROLOGY, 2000, 74 (01) :42-48
[2]   Association between the first two immunoglobulin-like domains of the neural cell adhesion molecule N-CAM [J].
Atkins, AR ;
Osborne, MJ ;
Lashuel, HA ;
Edelman, GM ;
Wright, PE ;
Cunningham, BA ;
Dyson, HJ .
FEBS LETTERS, 1999, 451 (02) :162-168
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[5]   The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses [J].
Bergelson, JM ;
Krithivas, A ;
Celi, L ;
Droguett, G ;
Horwitz, MS ;
Wickham, T ;
Crowell, RL ;
Finberg, RW .
JOURNAL OF VIROLOGY, 1998, 72 (01) :415-419
[6]   Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR [J].
Bewley, MC ;
Springer, K ;
Zhang, YB ;
Freimuth, P ;
Flanagan, JM .
SCIENCE, 1999, 286 (5444) :1579-1583
[7]   CRYSTAL-STRUCTURE OF THE EXTRACELLULAR REGION OF THE HUMAN CELL-ADHESION MOLECULE CD2 AT 2.5-ANGSTROM RESOLUTION [J].
BODIAN, DL ;
JONES, EY ;
HARLOS, K ;
STUART, DI ;
DAVIS, SJ .
STRUCTURE, 1994, 2 (08) :755-766
[8]  
BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582
[9]   Purification of the putative coxsackievirus B receptor from HeLa cells [J].
Carson, SD ;
Chapman, NN ;
Tracy, SM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (02) :325-328
[10]  
Chrétien I, 1998, EUR J IMMUNOL, V28, P4094